Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.

@article{Ding2017IdentificationOM,
  title={Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.},
  author={Dongbing Ding and Yao Yao and Changming Yang and Songbai Zhang},
  journal={Cancer biomarkers : section A of Disease markers},
  year={2017},
  volume={21 3},
  pages={
          689-700
        }
}
The aim of present study was to investigate the clinical significances of mannose receptor (MR) and CD163 in colorectal cancer (CRC). Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry (IHC) were utilized for this analysis. Preoperative serum MR and CD163 levels ranged from 0.153 to 0.804 μg/ml (median = 0.359 μg/ml) and from 0.319 to 1.314 μg/ml (median = 0.685 μg/ml) in CRC patients respectively. Strikingly, preoperative serum levels of MR and CD163 were significantly… CONTINUE READING